Aurobindo Pharma
BSE: 524804
|
NSE: AUROPHARMA
Aurobindo Pharma
(CIN: L24239TG1986PLC015190)
operates in the Pharmaceuticals industry and has been listed in the stock market since 06 Apr 1995.
It currents trades on NSE with symbol AUROPHARMA and on BSE with scrip code 524804.
The registered office of the company is Plot No.2, Maitrivihar, Ameerpet, Hyderabad, Telangana - 500038.
The management team of Aurobindo Pharma is led by Mangalam Ramasubramanian Kumar who is the Non-Executive - Independent Director-Chairperson. Other members of the management team consist of Santhanam Subramanian (Designation:Chief Financial Officer), Nithyananda Reddy Kambam (Designation:Executive Director-MD), Madan Mohan Reddy Mettu (Designation:Executive Director), Venkata Ramprasad Reddy Penaka (Designation:Non-Executive - Non Independent Director), Sarath Chandra Reddy Penaka (Designation:Non-Executive - Non Independent Director), Girish Paman Vanvari (Designation:Non-Executive - Independent Director), Santanu Mukherjee (Designation:Non-Executive - Independent Director), Satakarni Makkapati (Designation:Non-Executive - Non Independent Director), Punita Kumar Sinha (Designation:Non-Executive - Independent Director), B Adi Reddy (Designation:Company Secretary & Compliance Officer), .
The price and other financial information of Aurobindo Pharma is as below -
The registered office of the company is Plot No.2, Maitrivihar, Ameerpet, Hyderabad, Telangana - 500038.
The management team of Aurobindo Pharma is led by Mangalam Ramasubramanian Kumar who is the Non-Executive - Independent Director-Chairperson. Other members of the management team consist of Santhanam Subramanian (Designation:Chief Financial Officer), Nithyananda Reddy Kambam (Designation:Executive Director-MD), Madan Mohan Reddy Mettu (Designation:Executive Director), Venkata Ramprasad Reddy Penaka (Designation:Non-Executive - Non Independent Director), Sarath Chandra Reddy Penaka (Designation:Non-Executive - Non Independent Director), Girish Paman Vanvari (Designation:Non-Executive - Independent Director), Santanu Mukherjee (Designation:Non-Executive - Independent Director), Satakarni Makkapati (Designation:Non-Executive - Non Independent Director), Punita Kumar Sinha (Designation:Non-Executive - Independent Director), B Adi Reddy (Designation:Company Secretary & Compliance Officer), .
The price and other financial information of Aurobindo Pharma is as below -
Volume: 1,13,446.00
M. Cap: 89,088.91
P/E: 25.43
Prev. Close: 1,496.00
Day
52 Wk
Volume: 19,27,960.00
M. Cap: 89,083.11
P/E: 25.43
Prev. Close: 1,491.90
Day
52 Wk
Stock Price Chart
F&O Data
| expiry_date | open_price | high_price | low_price | prev_close | last_price | volume | turnover_lacs | underlying_value |
|---|---|---|---|---|---|---|---|---|
| 30-Jun-2026 | 1,499.00 | 1,546.00 | 1,499.00 | 1,497.60 | 1,541.00 | 5,242 | 44,104.51 | 1,534.80 |
| 28-Jul-2026 | 1,516.00 | 1,553.00 | 1,516.00 | 1,506.60 | 1,546.50 | 2,212 | 18,702.91 | 1,534.80 |
| 25-Aug-2026 | 1,534.00 | 1,557.80 | 1,534.00 | 1,508.00 | 1,549.00 | 35 | 298.56 | 1,534.80 |
| Calls | 30 Jun 2026 | Puts | ||||||
|---|---|---|---|---|---|---|---|---|
| OI (Delta OI) |
LTP (Change) |
Intrinsic Value | Time Value | Strike Price | Time Value | Intrinsic Value | LTP (Change) |
OI (Delta OI) |
| 1,100 (-) |
- |
0 | - | 1,160 | - | - | - |
- |
| - |
- |
- | - | 1,180 | - | 491.5 | - |
2,200 (-) |
| 29,700 (-) |
- |
0 | - | 1,200 | -511 | 511.5 | 0.50 (+0.05) |
58,300 (+19,800) |
| 4,400 (-) |
- |
0 | - | 1,220 | - | - | - |
- |
| 5,500 (-) |
299.20 (+38.95) |
0 | 299 | 1,240 | -551.2 | 551.5 | 0.30 (-0.20) |
23,100 (-1,100) |
| 3,300 (-) |
279.70 (+39.65) |
0 | 280 | 1,260 | -570.8 | 571.5 | 0.70 (+0.25) |
19,800 (-18,700) |
| 8,800 (-) |
259.40 (+44.95) |
0 | 259 | 1,280 | - | 591.5 | - |
13,200 (-) |
| 12,100 (-) |
- |
0 | - | 1,300 | -611 | 611.5 | 0.50 (+0.05) |
63,800 (-18,700) |
| 7,700 (-) |
- |
0 | - | 1,320 | -631.05 | 631.5 | 0.45 (-0.10) |
23,100 (-5,500) |
| - |
- |
- | - | 1,340 | -651.1 | 651.5 | 0.40 (-0.25) |
1,56,200 (-20,900) |
| 26,400 (-) |
180.05 (+40.25) |
0 | 180 | 1,360 | -670.9 | 671.5 | 0.60 (-0.20) |
1,59,500 (+3,300) |
| 1,36,400 (-) |
151.35 (+34.35) |
0 | 151 | 1,380 | -690.9 | 691.5 | 0.60 (-0.60) |
1,60,600 (+4,400) |
| 2,34,300 (-19,800) |
140.65 (+41.95) |
0 | 141 | 1,400 | -710.5 | 711.5 | 1.00 (-1.00) |
6,83,100 (-1,44,100) |
| 1,71,600 (-26,400) |
117.00 (+38.40) |
0 | 117 | 1,420 | -729.8 | 731.5 | 1.70 (-1.00) |
3,30,000 (+17,600) |
| 4,30,100 (-7,700) |
98.75 (+36.95) |
0 | 99 | 1,440 | -749.6 | 751.5 | 1.90 (-2.85) |
5,69,800 (-11,000) |
| 7,89,800 (-1,100) |
78.90 (+34.50) |
0 | 79 | 1,460 | -769.05 | 771.5 | 2.45 (-5.95) |
9,69,100 (-3,10,200) |
| 5,06,000 (-1,51,800) |
62.35 (+31.15) |
0 | 62 | 1,480 | -787.5 | 791.5 | 4.00 (-11.25) |
8,64,600 (+1,90,300) |
| 12,54,000 (-9,46,000) |
46.55 (+25.40) |
0 | 47 | 1,500 | -803.75 | 811.5 | 7.75 (-17.05) |
8,09,600 (+3,15,700) |
| 3,92,700 (+14,300) |
32.00 (+18.30) |
0 | 32 | 1,520 | -818.6 | 831.5 | 12.90 (-23.75) |
4,98,300 (+3,59,700) |
| 10,08,700 (+6,56,700) |
22.00 (+13.05) |
0 | 22 | 1,540 | -828.6 | 851.5 | 22.90 (-29.45) |
4,93,900 (+4,43,300) |
| 3,50,900 (+3,300) |
14.40 (+8.50) |
0 | 14 | 1,560 | -836.05 | 871.5 | 35.45 (-29.10) |
92,400 (+33,000) |
| 6,31,400 (+85,800) |
9.30 (+5.35) |
0 | 9 | 1,580 | - | - | - |
- |
| 19,98,700 (-85,800) |
6.85 (+3.65) |
0 | 7 | 1,600 | -844.3 | 911.5 | 67.20 (-48.05) |
19,800 (-6,600) |
| 2,86,000 (+17,600) |
5.05 (+2.75) |
0 | 5 | 1,620 | - | 931.5 | - |
5,500 (-) |
| 82,500 (+44,000) |
3.15 (+1.35) |
0 | 3 | 1,640 | - | 951.5 | - |
3,300 (-) |
| 1,03,400 (+24,200) |
1.70 (+0.55) |
0 | 2 | 1,680 | - | 991.5 | - |
3,300 (-) |
| 97,900 (+25,300) |
1.50 (+0.85) |
0 | 2 | 1,720 | - | 1031.5 | - |
5,500 (-) |
| 9,900 (+2,200) |
1.10 (-0.90) |
0 | 1 | 1,760 | - | - | - |
- |
Shareholding Pattern
| Category | No. of shares | Percent(%) |
|---|---|---|
| Promoters | 30,09,48,721 | 51.82 |
| Pledge | 7,11,60,000 | 23.65 |
| Foreign Institutions | 8,84,96,709 | 15.24 |
| Financial Institutions | 14,99,55,473 | 25.82 |
| NBFC and Mutual Funds | 10,33,08,668 | 17.79 |
| Others | 4,14,00,720 | 7.12 |
| Total | 75,52,70,291 | 141.44 |
Financial Data
Consolidated
| Figures in crore | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Sales | 31,723.73 | 29,001.87 | 24,855.38 |
| Operating Profit | 7,172.95 | 6,191.36 | 3,997.56 |
| Other Income | 621.85 | 557.38 | 290.59 |
| Interest | 457.24 | 289.71 | 140.48 |
| Depreciation | 1,649.42 | 1,521.66 | 1,244.58 |
| Profit Before Tax | 5,066.29 | 4,379.99 | 2,612.50 |
| Tax | 1,582.72 | 1,211.02 | 684.85 |
| Profit After Tax | 3,483.57 | 3,168.97 | 1,927.65 |
| Share Capital | 60.35 | 58.59 | 58.59 |
| Reserves | 32,595.24 | 29,784.21 | 26,781.26 |
| Net Worth | 32,655.59 | 29,842.80 | 26,839.85 |
| Loans | 8,612.17 | 6,925.22 | 5,500.47 |
| Gross Block | 24,462.96 | 23,447.77 | 18,593.32 |
| Investments | 251.71 | 372.23 | 542.74 |
| Cash | 8,235.49 | 6,278.30 | 6,084.20 |
| Debtors | 5,745.93 | 4,816.74 | 4,466.38 |
| Net Working Capital | 21,315.51 | 18,042.28 | 15,395.88 |
| Operating Profit Margin (%) | 22.61 | 21.35 | 16.08 |
| Net Profit Margin (%) | 10.98 | 10.93 | 7.76 |
| EPS | 60.02 | 54.16 | 32.90 |
| Dividend (%) | 0.00 | 450.00 | 750.00 |
| Dividend Payout | 0.00 | 263.66 | 439.45 |
Standalone
| Figures in crore | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Sales | 10,933.30 | 10,645.64 | 8,457.00 |
| Operating Profit | 2,885.69 | 2,894.14 | 1,933.77 |
| Other Income | 328.12 | 670.10 | 443.92 |
| Interest | 230.04 | 182.60 | 74.58 |
| Depreciation | 297.20 | 254.58 | 243.26 |
| Profit Before Tax | 2,358.45 | 2,456.96 | 1,615.93 |
| Tax | 611.66 | 502.82 | 388.82 |
| Profit After Tax | 1,746.79 | 1,954.14 | 1,227.11 |
| Share Capital | 58.08 | 58.59 | 58.59 |
| Reserves | 20,476.03 | 19,664.23 | 17,975.44 |
| Net Worth | 20,534.11 | 19,722.82 | 18,034.03 |
| Loans | 4,699.90 | 2,906.74 | 4,290.47 |
| Gross Block | 4,230.61 | 4,043.49 | 6,214.71 |
| Investments | 15,209.57 | 13,393.44 | 8,105.37 |
| Cash | 298.36 | 94.34 | 373.41 |
| Debtors | 4,195.05 | 3,776.59 | 4,560.26 |
| Net Working Capital | 7,600.11 | 6,684.31 | 10,292.54 |
| Operating Profit Margin (%) | 26.39 | 27.19 | 22.87 |
| Net Profit Margin (%) | 15.98 | 18.36 | 14.51 |
| Earning Per Share (Rs) | 30.08 | 33.35 | 20.94 |
| Dividend (%) | 0.00 | 450.00 | 750.00 |
| Dividend Payout | 0.00 | 263.66 | 439.45 |
| Bonus History | Date | Ratio |
|---|---|
| 20 Jul 2015 | issue issue 1:1 |
Financial Data Graph
The peers of Aurobindo Pharma are LUPIN, DIVISLAB and TORNTPHARM. You can get more detailed information on those company by clicking on the respective names.
* The above data is collected from public sources and we do not guarantee the accuracy of the same.*
Popular Comments
No comment posted for this article.